VMRC-MELGHomo sapiens (Human)Cancer cell line

Also known as: Virginia Mason Research Center-Melanoma G, Leggee, VMRCMELG

🤖 AI SummaryBased on 2 publications

Quick Overview

Human melanoma cell line for cancer research.

Detailed Summary

The VMRC-MELG cell line is derived from a human melanoma, providing a valuable model for studying melanoma biology and therapeutic strategies. While specific details about its tissue origin, disease characteristics, and cell type are not explicitly provided, the cell line is utilized in cancer research to investigate genetic and molecular mechanisms underlying melanoma progression. Its applications include drug screening, gene expression analysis, and understanding tumor heterogeneity. Further characterization may be required to fully elucidate its properties and potential in cancer studies.

Research Applications

Cancer researchDrug screeningGene expression analysisTumor heterogeneity studies

Key Characteristics

Human-derivedMelanoma cell line
Generated on 6/17/2025

Basic Information

Database IDCVCL_1789
SpeciesHomo sapiens (Human)

Donor Information

Age CategoryUnknown
SexMale

Disease Information

DiseaseMelanoma
LineageSkin
SubtypeMelanoma
OncoTree CodeMEL

DepMap Information

Source TypeJCRB
Source IDACH-001704_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleCDKN2Ac.151-1G>AHomozygousSplice acceptor mutationUnknown, Unknown
MutationSimpleBRAFp.Val600Glu (c.1799T>A)Unspecified-PubMed=26214590

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10
D13S317
8,11
D16S539
12
D18S51
15,18
D21S11
27,32.2
D3S1358
14,16
D5S818
10,13
D7S820
8,10
D8S1179
14
FGA
19,23
Penta D
10,12
Penta E
5
TH01
6,7
TPOX
9,11
vWA
17
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).